MEDOTEX: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MEDOTEX
Largest movements
- Receivables within one year -€4,266
down €4,266 (-14.3%), from €29,773 to €25,507
of which Trade receivables: -€5,376
- Cash -€4,206
down €4,206 (-39.6%), from €10,610 to €6,403
mainly Other debts (-€17,006) and Investment in fixed assets (net) (-€289)
- Tangible fixed assets -€1,404
down €1,404 (-48.9%), from €2,868 to €1,464
- Other debts -€17,006
down €17,006 (-64.7%), from €26,294 to €9,288
- Tax, wage and social debts +€5,925
new in 2025: €5,925
- Profit (loss) carried forward +€1,272
up €1,272 (+7.6%), from -€16,641 to -€15,368
- Purchases and services +€37,813
up €37,813 (+40.9%), from €92,492 to €130,305
- Gross operating margin -€15,787
down €15,787 (-53.8%), from €29,321 to €13,534
- Write-downs -€15,402
no longer reported in 2025 (was €15,402)
- Other operating charges +€8,021
up €8,021 (+1,019%), from €787 to €8,808
- Depreciation -€7,109
down €7,109 (-80.8%), from €8,802 to €1,693
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €44,751 | €35,099 | -€9,653 | -21.6% |
| Fixed assets | 21/28 | €2,868 | €1,464 | -€1,404 | -48.9% |
| Tangible fixed assets | 22/27 | €2,868 | €1,464 | -€1,404 | -48.9% |
| Plant, machinery and equipment | 23 | €2,868 | €1,464 | -€1,404 | -48.9% |
| Current assets | 29/58 | €41,883 | €33,634 | -€8,249 | -19.7% |
| Stocks and contracts in progress | 3 | €1,500 | €1,500 | = | 0.0% |
| Stocks | 30/36 | €1,500 | €1,500 | = | 0.0% |
| Amounts receivable within one year | 40/41 | €29,773 | €25,507 | -€4,266 | -14.3% |
| Trade receivables | 40 | €15,212 | €9,836 | -€5,376 | -35.3% |
| Other amounts receivable | 41 | €14,561 | €15,671 | +€1,110 | +7.6% |
| Cash at bank and in hand | 54/58 | €10,610 | €6,403 | -€4,206 | -39.6% |
| Deferred charges and accrued income | 490/1 | - | €224 | +€224 | |
| Total equity and liabilities | 10/49 | €44,751 | €35,099 | -€9,653 | -21.6% |
| Equity | 10/15 | €12,023 | €13,295 | +€1,272 | +10.6% |
| Contributions | 10/11 | €20,000 | €20,000 | = | 0.0% |
| Contributions outside capital | 11 | €20,000 | €20,000 | = | 0.0% |
| Other | 1109/19 | €20,000 | €20,000 | = | 0.0% |
| Reserves | 13 | €8,663 | €8,663 | = | 0.0% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,860 | €1,860 | = | 0.0% |
| Distributable reserves | 133 | €6,803 | €6,803 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€16,641 | -€15,368 | +€1,272 | +7.6% |
| Amounts payable | 17/49 | €32,729 | €21,804 | -€10,925 | -33.4% |
| Amounts payable within one year | 42/48 | €32,729 | €21,804 | -€10,925 | -33.4% |
| Financial debts | 43 | €3,751 | €3,747 | -€4 | -0.1% |
| Credit institutions | 430/8 | €3,751 | €3,747 | -€4 | -0.1% |
| Trade debts | 44 | €2,684 | €2,844 | +€160 | +6.0% |
| Suppliers | 440/4 | €2,684 | €2,844 | +€160 | +6.0% |
| Taxes, remuneration and social security | 45 | - | €5,925 | +€5,925 | |
| Taxes | 450/3 | - | €5,925 | +€5,925 | |
| Other amounts payable | 47/48 | €26,294 | €9,288 | -€17,006 | -64.7% |
| Goods, raw materials, services and sundry goods | 60/61 | €92,492 | €130,305 | +€37,813 | +40.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €8,802 | €1,693 | -€7,109 | -80.8% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | €15,402 | - | -€15,402 | |
| Other operating charges | 640/8 | €787 | €8,808 | +€8,021 | +1,019% |
| Gross operating margin | 9900 | €29,321 | €13,534 | -€15,787 | -53.8% |
| Operating profit (loss) | 9901 | €4,330 | €3,033 | -€1,297 | -30.0% |
| Financial income | 75/76B | €0 | €1 | +€1 | +12,000% |
| Recurring financial income | 75 | €0 | €1 | +€1 | +12,000% |
| Financial charges | 65/66B | €1,381 | €1,762 | +€381 | +27.6% |
| Recurring financial charges | 65 | €1,381 | €1,762 | +€381 | +27.6% |
| Profit (loss) for the period before taxes | 9903 | €2,949 | €1,272 | -€1,677 | -56.9% |
| Profit (loss) for the period | 9904 | €2,949 | €1,272 | -€1,677 | -56.9% |
| Profit (loss) for the period to be appropriated | 9905 | €2,949 | €1,272 | -€1,677 | -56.9% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 17 October 2026 via checked.be.